Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
GLOW Peptide Storage & Handling Storage Reference (All Three Compounds) State Lyophilized (Powder Form) BPC-157 -4 F (-20 C) long-term TB-500 -4 F (-20 C) long-term GHK-Cu -4 F (-20 C) long-term State Reconstituted (Liquid Form) BPC-157 35.6-46.4 F (2-8 C), up to 30 days TB-500 35.6-46.4 F (2-8 C), 1-2 weeks GHK-Cu 35.6-46.4 F (2-8 C), up to 30 days State Appearance BPC-157 Clear TB-500 Clear GHK-Cu May be light blue/green State Freeze reconstituted BPC-157 Aliquots possible TB-500 Do not freeze GHK-Cu Do not freeze TB-500 has the shortest reconstituted-stability window
R., Schnepp, P
Lower disease activity is a predictor of remission after tapering in PsA patients, while concomitant csDMARDs treatment does not have an impact on flare risk [151]
Therapeutic Research Protocol Dose: 0.5 0.9 mg (= 1018 clicks) Duration: 3 4 weeks Frequency: 2 daily, divided doses Cycle Interval: 4 weeks off before repeating Goal / Description: Higher-dose protocol used in stress-response and GABAergic modulation studies
Preclinical Toxicology: What Animal Studies Show The most reassuring data for accidental overdose comes from acute toxicity testing
US$ 28.12
US$ 28.74
US$ 27.88
US$ 25.43